Mule Edward A's Form 4 filing
Keenova Therapeutics plc (MNKTQ) · filed Nov 19, 2025
- Accession no.
- 0001193125-25-288480
- Filed
- Nov 19, 2025, 6:39 PM ET
- Trade date
- Nov 17-19, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $6.04M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mule Edward ACIK 0001029625 | 10% Owner |
| Silver Point Capital L.P.CIK 0001332784 | 10% Owner |
| O'Shea Robert JCIK 0001382617 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Common Stock | PPurchaseAcquired | +26,000 | $88.88 | +$2,310,750 | 4,529,740 | Direct | |
| Nov 19, 2025 | Common Stock | PPurchaseAcquired | +42,000 | $88.88 | +$3,732,750 | 4,571,740 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.